61 related articles for article (PubMed ID: 3941479)
1. Pathologic features of surgically excised human umbilical vein grafts.
Guidoin R; Gagnon Y; Roy PE; Marois M; Johnston KW; Batt M
J Vasc Surg; 1986 Jan; 3(1):146-54. PubMed ID: 3941479
[TBL] [Abstract][Full Text] [Related]
2. Biologic and structural evaluation of 80 surgically excised human umbilical vein grafts.
Julien S; Gill F; Guidoin R; Guzman R; Charara J; Roy PE; Marois M; Laroche G; Batt M; Roy P
Can J Surg; 1989 Mar; 32(2):101-7. PubMed ID: 2920312
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical vein grafts as infrainguinal bypasses: long-term clinical follow-up and pathological investigation of explanted grafts.
Batt M; Gagliardi JM; Avril G; Guzman R; Guidoin R; Hassen-Khodja R; Marois M; Le Bas P
Clin Invest Med; 1990 Aug; 13(4):155-64. PubMed ID: 2208831
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of the acute thrombogenicity of the modified human umbilical vein and autologous artery.
Björck CG; Bergqvist D; Dougan P; Esquivel C; Nilsson B
J Vasc Surg; 1985 May; 2(3):434-42. PubMed ID: 3999235
[TBL] [Abstract][Full Text] [Related]
5. Scanning electron microscopy evaluation of porous and nonporous arterial substitutes.
Ratto GB; Lunghi C; Spinelli E; Agati R; Tomellini M; Motta G
Surg Gynecol Obstet; 1982 Sep; 155(3):358-62. PubMed ID: 6214034
[TBL] [Abstract][Full Text] [Related]
6. Biogenic grafts in arterial surgery--long-term results (I. The homologous vein--II. The modified heterologous bovine carotid artery--III. The human umbilical vein).
Sciacca V; Walter G; Becker HM
Thorac Cardiovasc Surg; 1984 Jun; 32(3):157-64. PubMed ID: 6206595
[TBL] [Abstract][Full Text] [Related]
7. An histo-morphological evaluation of ninety surgically excised human umbilical vein grafts.
Gill F; Guzman R; Guidoin R; Avril G; Charara J; Batt M; Roy PE; Marois M; Graham AM; Symes JF
J Biomed Mater Res; 1989 Dec; 23(A3 Suppl):363-80. PubMed ID: 2613744
[TBL] [Abstract][Full Text] [Related]
8. [Fibrous hyperplasia in femoro-popliteal bypasses using treated human umbilical veins].
Guidoin R; Roy PE; Langeron P; Puppinck P; Paynter R; Gosselin C
J Mal Vasc; 1987; 12(4):329-33. PubMed ID: 3694057
[TBL] [Abstract][Full Text] [Related]
9. A pathological study of arterial prostheses surgically excised after overt clinical infection.
Chakfe N; Guidoin R; Marois M; Roy PE; Douville Y; Roy P; Batt M; Gosselin C
J Biomater Appl; 1991 Jan; 5(3):227-46. PubMed ID: 1826531
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic findings in synthetic and biologic explanted grafts used in peripheral arterial reconstruction.
Wagner E; Guidoin R; Marois M; Mantovani D; Roy R; Ricci M; Marois Y; King MW; Gill F; Awad JA
ASAIO J; 1994; 40(3):M279-83. PubMed ID: 8555524
[TBL] [Abstract][Full Text] [Related]
11. The use of autologous graft and human umbilical vein graft in femorocrural bypasses--a preliminary report.
Rondhuis JJ; van Iersel JG; Taks AC
Neth J Surg; 1985 Apr; 37(2):50-3. PubMed ID: 4000519
[TBL] [Abstract][Full Text] [Related]
12. The virgin, modified, human, umbilical vein graft: morphologic characteristics and mechanical properties.
Gagnon Y; Guidoin R; Downs AR; Martz H; DeEstable-Puig RF; Beaudoin G; Marois D; Laroche G; Roy P; Gosselin C
Can J Surg; 1986 Nov; 29(6):411-8. PubMed ID: 3779543
[TBL] [Abstract][Full Text] [Related]
13. Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs.
Harjula A
Ann Chir Gynaecol; 1981; 70(1):11-7. PubMed ID: 7259055
[TBL] [Abstract][Full Text] [Related]
14. [Autologous vein vs. human umbilical vein for femoropopliteal bypass].
Flørenes T; Zasada W; Pillgram-Larsen J; Dedichen H
Tidsskr Nor Laegeforen; 1993 Sep; 113(21):2681-3. PubMed ID: 8266287
[TBL] [Abstract][Full Text] [Related]
15. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia.
Neufang A; Espinola-Klein C; Dorweiler B; Savvidis S; Schmiedt W; Vahl CF
Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):583-9. PubMed ID: 17574877
[TBL] [Abstract][Full Text] [Related]
16. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.
Dardik H; Wengerter K; Qin F; Pangilinan A; Silvestri F; Wolodiger F; Kahn M; Sussman B; Ibrahim IM
J Vasc Surg; 2002 Jan; 35(1):64-71. PubMed ID: 11802134
[TBL] [Abstract][Full Text] [Related]
17. Umbilical vein grafts for vascular access in patients on long-term dialysis.
Wellington JL
Can J Surg; 1981 Nov; 24(6):608-9. PubMed ID: 7326623
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.
Dardik H; Ibrahim IM; Sussman B; Kahn M; Sanchez M; Klausner S; Baier RE; Meyer AE; Dardik II
Ann Surg; 1984 Jan; 199(1):61-8. PubMed ID: 6691733
[TBL] [Abstract][Full Text] [Related]
19. Reconstruction of large veins for nonmalignant venous occlusive disease.
Gloviczki P; Pairolero PC; Toomey BJ; Bower TC; Rooke TW; Stanson AW; Hallett JW; Cherry KJ
J Vasc Surg; 1992 Nov; 16(5):750-61. PubMed ID: 1433663
[TBL] [Abstract][Full Text] [Related]
20. Early and late comparison of umbilical vein and PTFE grafts in control and piroxicam-treated dogs.
Solis E; Hollier LH; Plate G; Dewanjee MK; Kaye MP
Int Angiol; 1986; 5(2):73-8. PubMed ID: 3746016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
